<DOC>
	<DOCNO>NCT01378169</DOCNO>
	<brief_summary>Aim study : The primary aim investigator study highlight presence biomarkers ( biological indicator presence inflammation infection ) infectious process systemic inflammatory response ( SIRS ) allow , first discriminate non-infectious inflammation infectious process secondary determine microbial pathogen responsive infection . For purpose investigator conduct combinatorial approach several blood marker include usual marker inflammation blood cell marker . Expression small piece RNA ( miRNA ) know inhibit determined gene expression , also analyse monocyte ( specific group white blood cell involve fist line defence microbes . Study design : For purpose investigator include 300 patient admit intensive care unit suspicion infection . Serial blood sample take biological parameter analysis . Efficiency single parameter different combination different marker determine presence absence infection responsive clinical inflammation study .</brief_summary>
	<brief_title>SIRS Bacterial Sepsis Discrimination Biomarkers ICU</brief_title>
	<detailed_description>Aim study : The project 's main objective establishment diagnostic performance association diagnostic marker infectious process link pathogen host systemic inflammatory response syndrome ( SIRS ) critical care patient allow , first discriminate non infectious SIRS sepsis , secondary determine microbial pathogen responsive inflammation . For purpose , conduct combinatorial approach several plasma marker include usual marker ( CRP , PCT , soluble mediator ( soluble TREM-1 , IL-6 , IL-1Ra , IL-10 , CXCL2 , CXCL8 , CCL2 CCL5 ) , cell marker ( CD14 / HLA-DR expression monocyte TLR2 , 4 , 9 expression NK cell ) together modify expression microRNA ( miRNA ) circulating monocyte . Study design : This study include patient admitted ICU SIRS suspect sepsis , accord usual criterion . Infection definition base combination clinical , bacteriological cyto-or histo-pathological accord disease involve . A serial measurement biological parameter previously describe realize D0 D3 . Evaluation criterion : The primary endpoint determine ability individual parameter different combination discriminate sepsis noninfectious inflammation . The diagnostic performance biomarkers study do calculate sensitivity , specificity , positive negative predictive value test alone combination respect existence infection ( sepsis ) ( SIRS ) . According data literature experience , expect proportion patient sepsis among holder SIRS 50 % . The discriminatory ability test perform use ROC curve calibration use Hosmer-Lemeshow several layer increase severity . The level service provide p-value &lt; 5 % . There plan statistical criterion stop search case biological data miss . The value area ROC curve ( AUC ) PCT 78 % ( 95 % CI 69-77 ) . Assuming one test combinatorial approach increase AUC 85 % , number patient need study estimate 300 . Conduct research : Study conduct 5 different site . Patients admit develop SIRS hospitalization include . There nothing peculiar therapeutic management patient covert international guideline . - Inclusion criterion : - Patient admit develop SIRS ICU hospitalisation - Two parameter SIRS definition - Patient preclude participation study - Non inclusion criterion - Decision withdrawal withhold therapeutic intervention - No affiliation social security scheme The measurement biological endpoint conduct daily , D0 ( admission ) D2 use blood sample . The study monocyte expression miRNA perform portion cohort , correspond patient select St. Joseph site ( intensive care unit surgical intensive care unit ) complexity implement , cost level ( require specific funding ) . Total projected duration search : The recruitment period run 23 month aim include 300 patient . Patients include research follow day 28 day hospital leaving , early . Stopping rule study patient : patient discontinue participation time research . Security evaluation : Being non-interventional study ( biological collection ) usual care patient , serious adverse event expect related research . Any new data security , potentially lead reassessment benefit risk research , may sufficient consider change conduct research must report .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Age &gt; = 18 year Patient hospitalize ICU diagnosis SIRS : Temperatures 38 ° C 36 ° C At least one criterion : Heart rate &gt; 90 bpm Respiratory rate 20 breath / min PaCO2 &lt; 32 mmHg Leukocytosis great less 4000/mm3 12000/m3 Patient admit intensive care less 12 hour Patient preclude participation study . Decision limit treatment potential inclusion study No affiliation social security scheme ( beneficiary assignee )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>SIRS</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Severe Sepsis</keyword>
	<keyword>Septic Shock</keyword>
	<keyword>Inflammatory process</keyword>
	<keyword>Cytokines</keyword>
	<keyword>HLA-DR</keyword>
	<keyword>HLA type II</keyword>
	<keyword>Chemokines</keyword>
	<keyword>TLR expression</keyword>
	<keyword>mRNA expression whole blood</keyword>
	<keyword>Bacterial DNA detection</keyword>
	<keyword>Prognosis factor</keyword>
	<keyword>Infection</keyword>
	<keyword>Diagnosis</keyword>
</DOC>